Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Tel Aviv
SEC filing record 1 source field available
Fiscal year end
31 December
TEVA PHARMACEUTICAL INDUSTRIES LTD has filed 2,493 SEC EDGAR filings since 02 Feb 1996

SEC filing history

Showing 451-475 of 1,000 matching filings.

Per page
25
Current page
19
4

FORM 4 SUBMISSION

Filing date
08 Mar 2022
Reporting date
04 Mar 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
08 Mar 2022
Reporting date
04 Mar 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
08 Mar 2022
Reporting date
04 Mar 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
08 Mar 2022
Reporting date
04 Mar 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
02 Mar 2022
Reporting date
28 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
02 Mar 2022
Reporting date
28 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
02 Mar 2022
Reporting date
28 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
02 Mar 2022
Reporting date
28 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
02 Mar 2022
Reporting date
28 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
02 Mar 2022
Reporting date
28 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
02 Mar 2022
Reporting date
28 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
02 Mar 2022
Reporting date
28 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
02 Mar 2022
Reporting date
28 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
02 Mar 2022
Reporting date
28 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
02 Mar 2022
Reporting date
28 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
15 Feb 2022
Reporting date
13 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-55457

SEC SCHEDULE 13G

Filing date
11 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
5

FORM 5 SUBMISSION

Filing date
10 Feb 2022
Reporting date
31 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
10 Feb 2022
Reporting date
08 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
10 Feb 2022
Reporting date
08 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
10 Feb 2022
Reporting date
08 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
10 Feb 2022
Reporting date
08 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
10 Feb 2022
Reporting date
08 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
10 Feb 2022
Reporting date
08 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .